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Abstract
Background Even though there are multiple studies
documenting the outcome of the Charnley low-friction
arthroplasty as well as abundant studies on uncemented
arthroplasties, there is a dearth of comparative studies of
the uncemented acetabular component and a cemented
component. In this study we aimed to document the long-
term clinical and radiographic outcome as well as com-
ponent survival in a randomized controlled trial.
Materials and methods Two hundred ﬁfteen patients (240
hips) were randomly allocated to receive a cemented
Charnley cup or uncemented Duraloc 1200 cup. All
patients received cemented Charnley stems and were
evaluated clinically and radiographically after 6 months,
and 2, 5, and 10 years.
Results Harris Hip Scores improved from 48.3 [95%
conﬁdence interval (CI) 45.0–51.6] to 90.2 [95% CI 87.9–
92.6] in the Charnley group and from 49.3 [95% CI 86.9–
91.3] in the Duraloc group at 6 months. After 10 years, the
Charnley group’s Harris Hip Score was 89.8 [95% conﬁ-
dence interval (CI) 87.0–92.6], and the Duraloc group’s
score was 87.3 (95% CI 84.1–90.6). In the radiographic
analysis after 10 years, there was no statistical difference in
the prevalence of radiographic signs of loosening. Nine
cups were revised in the Charnley group, and ﬁve cups
were removed in the Duraloc group. The difference was not
statistically signiﬁcant. There was no statistical difference
between the cups when aseptic loosening was the end-
point, nor in survival analyses.
Conclusions There is no statistically signiﬁcant differ-
ence in clinical or radiological outcome between the
Charnley cup and the Duraloc after 10 years, and no
difference in implant survival after 12–14 years. The
uncemented Duraloc cup is as good as the cemented
Charnley cup after 10 years.
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Randomized
Introduction
Hip arthroplasty is a highly successful procedure for alle-
viating pain and improving overall hip function in arthritis
and other destructive hip joint conditions [1]. However, the
method of ﬁxation for hip replacement components has
remained a matter of controversy [2, 3].
The cemented all-polyethylene acetabular component
has been regarded as a gold standard, and multiple reports
conﬁrm survival of 85–92% after 16–25 years [4–6] and
revision rates of 2–17% after 17–30 years [7–10] when
aseptic loosening is the end-point. However, results are
worse for younger patients, and rates of revision increase
with longer follow-up [5].
The uncemented acetabular component has been regar-
ded as a viable alternative to the cemented cup [2], and the
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technique has emerged as the most commonly used com-
ponent [11]. Multiple series have demonstrated low rates of
revision when aseptic loosening is the end-point, but
revision due to osteolysis and polyethylene wear remains a
problem [12–15]. Survival of the shell after 8–12 years is
reported to be 100% in several studies when aseptic loos-
ening is the end-point [12, 16–19], whereas survival of the
acetabular component may be 64–80% when liner
exchange, osteolysis, and wear are end-points [12, 14, 16,
20]. In a study of a ﬁrst-generation porous-coated cup
(PCA) with 15–17 years follow-up, 17% of the cups had
been revised due to loosening with or without osteolysis
[21], whereas a recent 20-year study found 96% survival of
shell and 17% liner revision rate [15].
As the acetabular component of the Charnley arthro-
plasty has remained virtually unchanged for close to
40 years, there is an abundance of clinical studies docu-
menting the results of the cemented acetabular component.
A recent PubMed search yielded more than 400 studies on
the Charnley arthroplasty, but only 8 were comparative
studies [22–29], and only 1 compared the Charnley with a
modern hemispheric porous-coated press-ﬁt cup [30]. This
was a radiostereometric study in 21 patients which found
no difference between the Charnley cup and the Harris
Galante cup in terms of ﬁxation.
Thus there is a lack of good evidence with regards to the
comparative outcome of the modern porous-coated cup and
the traditional cemented all-polyethylene cup. Randomized
controlled studies provide the best evidence, and in this
report we convey the results of a randomized controlled
trial comparing the Duraloc cup with a conventional
Charnley cup with 10–14 year follow-up to help resolve
the lack of evidence from direct comparisons of these two
hip arthroplasty techniques.
Patients and methods
Between April 1994 and June 1997, 215 patients treated at
one clinic consented to take part in the study, which was
conducted at a county hospital with an annual case load of
300 total hip replacements. According to the inclusion
criteria, patients were eligible for participation in the study
if they suffered from noninﬂammatory degenerative
disease of the hip including osteoarthritis, posttraumatic
arthritis, psoriatic arthritis, and gout. They were also eli-
gible if they suffered from joint diseases of inﬂammatory
origin such as rheumatoid arthritis and juvenile rheumatoid
arthritis as well as systemic lupus erythematosus. The
upper age limit was 75 years, but there was no lower age
limit. Previous prosthetic replacement was a contraindica-
tion to participation, but osteotomies and internal ﬁxations
were not. Twenty-ﬁve patients consented for both of their
hips, resulting in a total of 240 hips enrolled. Patients were
given sequential enrollment numbers, but the assignment of
patients to treatment groups was randomly chosen using a
table of random numbers. The randomization was con-
cealed until after surgery had been initiated. In order to
reduce potential bias, patients were not told which ace-
tabular implant they received until their 2-year follow-up
visit, which was covered in the preoperative consent form.
Patients were grouped in accordance with the Charnley
classiﬁcation (Table 1) to allow stratiﬁcation according to
presence of comorbidities and condition of other joints
[31]. Surgery was performed using a direct lateral approach
[32] by ﬁve orthopedic surgeons. The femoral component
was cemented using third-generation cementing techniques
with vacuum mixing, retrograde ﬁlling of the canal, and
pressurization prior to insertion of the femoral component
[33]. Cement containing gentamycin and a Charnley stem
(DePuy, Leeds, UK) with 22.225 mm head diameter was
used in all cases.
For the uncemented group, the Duraloc 1200 cup
(DePuy, Leeds, UK), a hemispherical modular cup con-
sisting of a titanium shell with a porous-coated surface, was
used. The surface has a mean pore size of 250 lm. The
Duraloc 1200 cup was considered a second-generation cup
because it had a minimum polyethylene thickness of 6 mm,
dome-loading of the polyethylene, and an improved lock-
ing mechanism designed not to interfere with liner–
shell conformity [34]. The shell had a central hole for
the insertion device and 12 holes for screw ﬁxation.
An ultrahigh-molecular-weight polyethylene (UHMWPE)
liner (Enduron; DePuy, Leeds, UK) with a 10 posterior lip
was used in all cases.
The Charnley cup (DePuy, Leeds, UK) used for the
other group was an all-polyethylene cup with a ﬂange. The
Ogee cup was used in 101 cases and the Low Posterior
Wall cup was used in 19 cases. The surgeon cut the ﬂange
Table 1 Charnley classiﬁcation including modiﬁcation of group B
A Single-joint arthropathy and no signiﬁcant medical comorbidity
B One other joint in need of an arthroplasty, or an unsuccessful or failing arthroplasty in another joint
B1 Contralateral hip in need of arthroplasty, but untreated
B2 Contralateral hip has been successfully treated with an arthroplasty
C Multiple joints in need of arthroplasty, multiple failing arthroplasties or signiﬁcant medical or psychological impairment
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123to ﬁt the rim of the acetabulum, which provided increased
pressure to the cement, augmenting cement penetration
into the bone of the acetabulum. Surgery was performed
under laminar air ﬂow.
For prophylaxis against thromboembolic events,
dalteparin (Fragmin
), a low-molecular-weight heparin,
5000 IE was given subcutaneously on the night before
surgery, 4–8 h postoperatively, and daily for the length of
the stay. Cefuroxim (Zinacef
) was given routinely in the
study period as prophylaxis for infection. Patients were
screened for urinary-tract infection prior to surgery and
treated appropriately if bacteriuria was detected. Postop-
eratively, patients were allowed restricted weight bearing
on the day after surgery. All patients were encouraged to
use two crutches for at least 6 weeks.
The objectives of the study were to assess the safety and
efﬁcacy of the implants by means of clinical evaluation by
means of Harris Hip Score (HHS), and radiological eval-
uation after 6 months, and 2, 5, and 10 years, as well as
adverse event reporting. Though not part of the original
study protocol, we conducted an implant survival analysis
as well. No subgroup analysis was performed.
Patients were seen by their surgeon 6 weeks after sur-
gery and by a physiotherapist 6 months, and 2, 5, and
10 years after surgery. The physiotherapist was speciﬁcally
trained to evaluate hip replacement patients. The patients,
but not the physiotherapist, were blinded as to which
implant had been used in order not to bias the subjective
part of the evaluation. The physiotherapist obtained a
Harris Hip Score [35] at each visit. Radiographs were
obtained at all visits and analyzed by a radiologist not
directly involved in the study but very competent in this
ﬁeld. Radiographic changes that were noted included
radiolucencies, bone resorption, cortical hypertrophy,
cement fracture, and migration of components in the
femoral zones of Gruen [36] and acetabular zones of
DeLee [37]. No measure of polyethylene wear and no
formal quantiﬁcation of osteolysis was performed as this
was not a part of the original study protocol.
All patient charts were examined during the summer of
2008, and censoring dates were set to July 31, 2008 for
patient and implant survival. Thus, the follow-up was
12–14 years in the survival analysis. During the chart
review we collected information that was not included in
the protocol, including duration of surgery, bleeding, and
any secondary use of antibiotics that might indicate com-
plications not routinely recorded in the research protocol.
Statistical analysis
Two-sample t-tests were used for comparing continuous
data. Chi-square and Fisher exact test were used to com-
pare categorical variables. Survival data were analyzed
using Kaplan–Meier plots and log-rank test. Logistic
regression analysis was employed to explore possible risk
factors for prosthetic infection. Results are considered
statistically signiﬁcant when p-values are below 0.05 or
when the 95% conﬁdence intervals do not overlap. In 25
cases two arthroplasties were included in the study, and
these were analyzed as independent cases for reasons
outlined in the ‘‘Discussion.’’
Ethics
This study was initiated prior to the institution of a Insti-
tutional Review Board at our hospital. However, the pro-
cedures were conducted in accordance with the Declaration
of Helsinki and the study has been evaluated by the present
research ethics committee, which did not have any objec-
tions. All patients provided informed consent prior to
surgery.
Results
There were 58 men and 157 women enrolled in the study,
with mean body mass index (BMI) of 26.50 kg/m
2 (SD
3.4 kg/m
2) and 26.87 kg/m
2 (SD 4.5 kg/m
2), respectively.
There was a statistically signiﬁcant difference between the
Charnley and Duraloc group in the distribution of hips
between class A and B in the Charnley classiﬁcation
(Table 2; p = 0.049), with the Charnley group having
more B1 patients and the Duraloc group more A patients.
There was no statistically signiﬁcant difference in other
preoperative characteristics or baseline demographics
(Table 3) between the groups. Operative time was signiﬁ-
cantly longer for Charnley (71 min) than for Duraloc
Table 2 Preoperative characteristics of the patients according to
group
Diagnosis Charnley Duraloc
Osteoarthritis 93 94
Congenital hip dysplasia
a 24 18
Posttraumatic arthritis 2 4
Rheumatoid arthritis 1 3
Avascular necrosis 0 1
Class Charnley Duraloc
A4 6 6 6
B1 40 24
B2 29 25
C5 5
a Mild dysplasia not necessitating advanced acetabular procedures
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123(66 min) (p = 0.033), but there was no signiﬁcant differ-
ence in bleeding (636 versus 602 ml) (p = 0.295).
Follow-up
During the entire study period, 53 hips were lost due to the
death of the patient, 24 in the Charnley group and 29 in the
Duraloc group. However, only 25 patients died before their
10-year appointment, representing 12 cases in the Charnley
group and 14 cases in the Duraloc group (Fig. 1). We were
able to locate all patients in the study, but 31 patients were
not able to attend their 10-year appointment, mostly
because of ill health. Furthermore, 31 femoral revisions
were performed, 17 in the Charnley group and 14 in the
Duraloc group. For this reason, 71 patients in the Charnley
group and 80 patients in the Duraloc group were available
for 10-year Harris Hip Score and radiographic analysis.
Bilateral cases
The preoperative characteristics of the bilateral cases are
shown in Table 4. The patients who were included in the
study with two hips had a statistically signiﬁcant lower
BMI than the unilateral patients in the Duraloc group, but
not in the Charnley group.
Table 3 Baseline values of patient demographics
Charnley Duraloc
Mean 95% Conﬁdence interval Mean 95% Conﬁdence interval
Age (years) 65 64 66 66 65 67
Gender
a (%) 76 68 84 71 63 79
Harris Hip Score 47 45 50 49 47 52
Body mass index (kg/m
2) 2 72 7 2 8 2 72 6 2 7
a Proportion female
Included in study 
240 hips 
Allocated to Charnley: 120
Received treatment: 120 
Allocated to Duraloc 120 
Received treatment 120 
Revised: 14 
Dead: 14 
Lost to follow-up: 12
Revised: 18 
Dead: 12 
Lost to follow-up: 19
Analyzed: 71  Analyzed: 80 
Fig. 1 Flow diagram illustrating the ﬂow of hips through the study.
Numbers for revision include femoral revisions
Table 4 Baseline characteristics of the unilaterally and bilaterally
operated cases in the Charnley (91 and 29) and Duraloc (99 and 21)
groups
Acetabulum Mean 95% Conﬁdence interval for mean
Lower bound Upper bound
Charnley
Baseline HHS
Unilateral 46.7 43.8 49.5
Bilateral 49.8 43.3 56.3
Total 47.4 44.8 50.0
Age (years)
Unilateral 65.5 64.0 67.0
Bilateral 63.9 60.8 67.0
Total 65.1 63.7 66.4
BMI (kg/m
2)
Unilateral 27.4 26.4 28.3
Bilateral 25.3 24.1 26.5
Total 26.9 26.1 27.7
Duraloc
Baseline HHS
Unilateral 48.2 45.3 51.1
Bilateral 55.2 50.0 60.3
Total 49.4 46.9 52.0
Age (years)
Unilateral 66.2 64.8 67.7
Bilateral 64.4 60.8 68.1
Total 65.9 64.6 67.3
BMI (kg/m
2)
a
Unilateral 27.1 26.3 27.9
Bilateral 24.5 23.0 26.0
Total 26.7 25.9 27.4
a Signiﬁcant difference as evidenced by nonoverlapping conﬁdence
intervals
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123Harris Hip Score
There was a signiﬁcant difference between preoperative
and postoperative scores for both groups (p\0.0005). The
Harris Hip Score improved from a baseline score of 47.7 to
87.7 at 6 months in the Charnley group, and from 49.4 to
88.2 in the Duraloc group. The difference between the
intervention groups was not statistically signiﬁcant at any
time point (Table 5). There was a clear but not statistically
signiﬁcant decline in Harris Hip Score after 5 years in both
groups, with the decline starting earlier for the Duraloc
hips. Based on the function part of the Harris Hip Score,
there was a reduction in function for both groups starting at
2 years of follow-up (Fig. 2). The pain component of the
Harris Hip Score remained stable for both groups.
Revisions
A total of 13 acetabular components were revised during
the study (5.4%), 9 in the Charnley group and 4 in the
Duraloc group, which was not statistically signiﬁcant
(p = 0.12; chi-square). In the Charnley group, three cups
were revised due to aseptic loosening, one due to dislo-
cation, and ﬁve due to prosthetic infection.
The ﬁve hips that became infected were treated with
two-stage revision after 5, 11, 14, 24, and 48 months.
While the difference in the rate of prosthetic infection
between the groups was not quite statistically signiﬁcant
(p = 0.06; Fisher’s exact test), further exploration of the
reasons for the disproportionately high rate of infection in
the Charnley group revealed that the mean operating time
was longer in the infected group (83 versus 68 min;
p = 0.065) and the patients that became infected were
signiﬁcantly older (71.2 versus 65.4 years, p = 0.035) than
the patients who did not become infected. There was a
signiﬁcant association between secondary use of antibiotics
and later prosthetic infection (p = 0.001). Only 1 of the
188 cases who did not have a urinary infection developed a
hip infection, whereas 4 of the 41 cases with urinary
infection later sustained a prosthetic infection. In logistic
regression analysis, secondary use of antibiotics for any
reason signiﬁcantly increased risk of having a later pros-
thetic infection by 12.5 (CI 95% 1.2–133), after correction
for age, gender, comorbidities (Charnley class), surgeon,
and study group (Charnley versus Duraloc).
Of the four revised cups in the Duraloc group, no cups
were revised due to aseptic loosening. Three cups were
removed in conjunction with revision of a loose stem, and
one cup that did not show signs of being loose was
removed during revision for instability. There were no
isolated exchanges of liner, but the liner was changed en
passant in conjunction with femoral revision in nine cases
in the Duraloc group. If these liner exchanges were
included among the revisions, 13 Duraloc cups were
revised (11%) versus 9 Charnley cups (8%), a difference
that was still not statistically signiﬁcant (p = 0.37; chi-
square).
Implant survival
Survival of the implants was determined using Kaplan–
Meier survival analysis (Fig. 2) using revision for any
reason as end-point, except liner exchange en passant. The
curves (Fig. 2) indicate a slightly better survival for the
Duraloc cup for the ﬁrst 12 years, but the log-rank test
between the implants was not signiﬁcant (Mantel-Cox;
p = 0.09).
Dislocation and other complications
In the Charnley group, four patients had dislocations which
were treated by closed reduction. One patient was later
revised due to recurring instability from loosening of the
Table 5 Mean Harris Hip Score including conﬁdence intervals
(95%) for both interventions
Charnley Duraloc
CI CI
Mean Lower Upper Mean Lower Upper
Preoperative 48.3 45.0 51.6 49.3 46.3 52.4
6 months 90.2 87.9 92.6 89.1 86.9 91.3
2 years 92.7 89.6 95.8 94.0 92.4 95.7
5 years 93.9 91.6 96.2 91.4 89.3 93.5
10 years 89.8 87.0 92.6 87.3 84.1 90.6
Fig. 2 Survival in days of Charnley and Duraloc acetabular compo-
nents with revision for any reason as end-point
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123femur. In the Duraloc group, ten patients had dislocations,
one of which was later revised because of recurring
instability from loosening of the femur. Another patient in
the Charnley group and two in the Duraloc group reported
instability, but they did not have documented dislocation
necessitating reduction. Thus a total of 17 patients reported
instability, 5/120 in the Charnley group (3.3%) and 12/120
(10.0%) in the Duraloc group (p = 0.098).
There were 33 complications that were not treated sur-
gically, 15 in the Charnley group and 18 in the Duraloc
group (p = 0.32; Table 6). In the retrospective chart
review, 52 cases (24 in the Charnley group and 28 in the
Duraloc group) were identiﬁed in which a second course of
antibiotics was given, of which 41 cases were given anti-
biotics indicating a urinary infection and 11 cases were
other antibiotics indicating a range of infection types.
Radiographic results
For the acetabular component, 71 radiographs in the
Charnley group and 80 in the Duraloc group were obtained.
In the Charnley group, three patients had radiolucencies of
1 mm in zone A. One patient had changes in zones A and
C, while three patients had changes in all three zones. In
the Duraloc group, one patient had radiolucencies in
zone A. There was no migration of the cup in any of the
groups. Thus, 7/71 patients had some evidence of loosening
of the cup in one or more zones in the Charnley group,
while only 1/80 in the Duraloc group had any evidence of
loosening (p = 0.024).
Discussion
Both groups improved their Harris Hip Score signiﬁcantly
after surgery, and the magnitude of improvement compared
well with what is usually seen after total hip arthroplasty
[18, 38]. The difference in Harris Hip Score between the
implants was 2.4 points after 5 years and 2.5 points after
10 years, in favor of the Charnley cup. The study probably
did not have sufﬁcient power to detect a difference of this
magnitude as statistically signiﬁcant. Harris Hip Scores
between 90 and 100 are regarded as excellent, and we feel
that a clinically relevant difference between treatment
groups would have to be 5 points. In the study by
Kalairajah [38], the mean HHS was 89 and the standard
deviation was 13.3. In a study designed to detect a 5%
effect size with 80% power and 95% certainty and a
standard deviation of 13.3, one would need 87 subjects in
each treatment group. In our study, loss of patients due to
revision, death, and ill health was underestimated, resulting
in somewhat small samples.
The observed decline in HHS from 5 years in the
Charnley group and from 2 years in the Duraloc group is in
accordance with what is usually seen. When splitting the
Harris Hip Score into a pain component and a functional
component, it can be seen that the arthroplasties remain
pain free even though function declines. For this reason, we
feel that the decline in HHS corresponds to a decline in
general health due to aging of the patients, which has been
reported in some [23] but not all [39] earlier studies. This
supports the previous ﬁndings that call for a separate
instrument to assess activity level of the arthroplasty
patient beyond what is measured by the Harris Hip Score
[40].
There was a large discrepancy in the frequency of
infection which warrants more investigation. Five of the
240 arthroplasties became infected (2.1%), but all occurred
in the Charnley group. There was a signiﬁcant association
between urinary infection and later deep infection of the
hip, which is consistent with ﬁndings in previous reports
[41–43]. However, since we do not have information on the
infecting agent, it is not possible to suggest a causal rela-
tionship between urinary-tract infection and subsequent
prosthetic infection. However, the ﬁnding is interesting and
may suggest an underlying predisposition for infection. In
any case, the ﬁnding certainly represents a cautionary
reminder concerning perioperative instrumentation of the
urinary tract. On a slightly different note, it may be argued
that the patients who became infected should be removed
from the survival analysis, but we have elected to keep
them, since infection is an important aspect of implant
survival in the clinical setting.
The radiographic analysis indicated that 9.9% of the
Charnley cups and 1.2% of the Duraloc cups had some
signs of loosening. However, since none of them had
changed position, they were not deemed to be deﬁnitely
loose. In our study, we included any sign of loosening
larger than 1 mm noted by the radiologist in the analysis,
and many of these signs were probably very subtle. This
Table 6 Complications reported in the study that were not treated
surgically
Charnley Duraloc
Cardiovascular 0 1
CNS (stroke) 0 2
Pulmonary embolism 1 3
Hematemesis 1 0
Respiratory 1 0
Weakness of muscles 3 5
Wound problems 6 5
Other 3 2
CNS, central nervous system
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graphic signs of loosening, but the relationship between
radiographic signs and loosening is complicated, as
radiographically loose cups may function well clinically
whereas painful, loose cups do not always display deﬁnite
signs of loosening radiographically. Furthermore, we have
not studied wear and osteolysis, which are known to affect
predominantly uncemented cups. For this reason, our
ﬁndings may underestimate problems with uncemented
cups.
There are limitations to any long-term study of this
nature. Because of death and deterioration in general
health, only 59% in the Charnley group and 67% in the
Duraloc group were available for clinical and radiographic
evaluation at the 10-year mark. While it is has been shown
that the results in patients lost to follow-up are worse than
patients who stay in clinical studies [44], we were able to
determine reason for loss to follow-up for almost all of our
patients, with the vast majority of those who declined a
follow-up visit doing so because of advanced comorbid
diseases and not because of poor function of the hip. In
addition, our overall follow-up rate was similar to other
long-term studies of hip function [18, 19, 41], even though
our patient population was signiﬁcantly older. The gener-
alizability of the study is felt to be good as the study was
conducted at a nonacademic center, included most patients
under 75 years of age, and the surgery was performed by
general orthopedic surgeons.
The lack of precise recording of comorbidities is also a
limiting factor. Indices of comorbidities have previously
been shown to predict functional outcome as well as com-
plications after total hip arthroplasty [45–51]. The Charnley
score is not a dedicated comorbidity instrument and might
not be sensitive enough to record subtle nuances in patient
health status, which could have contributed to a better
understanding of the large discrepancy in infection rates
between the two study groups. Another limitation is the lack
of a formal account for patient activity level [40, 52]. Level
of activity is important as it is of primary interest to the
patients forperforming recreational activities [53] as well as
for improving physical ﬁtness, although increased level of
activity correlates with wear and potential failure of an
implant [54–56]. The Harris Hip Score contains assessment
of physical function, but it does not quantify what the
patient actually does, only what he or she is capable of
doing. Dedicated scales have been developed for the sole
purpose of estimating level of activity before and after total
hip arthroplasty (THA), but these scales were not available
for use in this study [56–59].
The issue of bilateral procedures is controversial since
the presence of two procedures in one patient violates the
assumption of independent observations on which many
statistical tests rely [60]. However, other authors have
discussed this and found that inclusion of bilateral proce-
dures did not alter the results [61, 62]. In a recent study from
the Finnish Arthroplasty Register, 27% of the cases ana-
lyzed were bilateral cases, and inclusion of bilateral cases in
the analysis was considered appropriate, even though the
statistical technique (Cox regression) formally requires
independent observations. In out study, 21% of the cases
were bilateral. We did ﬁnd statistically signiﬁcant differ-
ences in preoperative BMI, which raises the question of
whether other unknown confounders might inﬂuence the
results. However, the issue of bilaterality was not addressed
in the study protocol. The presence of an arthroplasty in the
contralateralhipwasnotanexclusioncriterionforthestudy,
nor was there any criterion excluding patients with poor
functionofthecontralateralhip.Forthesereasons,weﬁndit
justiﬁed to include the patients who had two arthroplasties
during the study and treat them as independent cases.
While the Charnley cup has remained unchanged since
the inception of this study, uncemented cups have under-
gone a continuous process of change. As screw-holes are
believed to transmit increased stress to the polyethylene, in
addition to providing a potential pathway for polyethylene
debris, a shell with 12 screw-holes is now rarely used in
primary surgery. Furthermore, the polyethylene used in
this study has largely been replaced by cross-linked poly-
ethylene (PE) or alternative bearings, and there is an
international trend moving toward larger head sizes. Nev-
ertheless, the Charnley low-friction arthroplasty continues
to be regarded by many as a gold standard against which
new implants are compared [63].
In conclusion, our 10-year results conﬁrm previous
reports from noncontrolled studies that survival of an
uncemented hemispherical porous-coated cup as well as
the cemented all-polyethylene cup is excellent. With no
statistically signiﬁcant differences in outcomes or survival
between the two implants, surgeons should choose the
system that they are either more familiar with in terms of
surgical technique or that would most beneﬁt the individual
patient. Further studies might indicate whether one implant
will perform better than the other in the long term.
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